Ginkgo Bioworks Holdings (DNA) Income from Non-Controlling Interests (2020 - 2022)

Ginkgo Bioworks Holdings (DNA) posted Income from Non-Controlling Interests of $2.4 million for Q4 2022, up 236.96% on a QoQ basis from -$1.7 million in Q2 2022, and up 155.08% year-over-year from $936954.3 in Q4 2021.

Ginkgo Bioworks Holdings (DNA) Income from Non-Controlling Interests (2020 - 2022) Analysis & Trends

Ginkgo Bioworks Holdings' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at $2.4 million for Q4 2022.

  • Quarterly Income from Non-Controlling Interests rose 155.08% year-over-year to $2.4 million in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $2.4 million (up 129.25% YoY) and the FY2022 annual result came in at -$1.4 million, up 78.12% from the prior year.
  • Income from Non-Controlling Interests was $2.4 million for Q4 2022 at Ginkgo Bioworks Holdings, up from -$1.7 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $2.4 million in Q4 2022 and bottomed at -$4.3 million in Q4 2021.
  • A 3-year average of -$968888.9 and a median of -$753000.0 in 2020 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2021 — Income from Non-Controlling Interests slumped 838.03% — and 2022, when it surged 155.08%.
  • Ginkgo Bioworks Holdings' Income from Non-Controlling Interests stood at -$753000.0 in 2020, then sank by 476.23% to -$4.3 million in 2021, then jumped by 155.08% to $2.4 million in 2022.
  • Business Quant data shows DNA's Income from Non-Controlling Interests at $2.4 million in Q4 2022, -$1.7 million in Q2 2022, and -$2.1 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Ginkgo Bioworks Holdings 441.96 Mn 298.10 Mn 16.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 2.39 Mn
Jun 30, 2022 -1.75 Mn
Mar 31, 2022 -2.09 Mn
Dec 31, 2021 -4.34 Mn
Sep 30, 2021 -524,000.00
Jun 30, 2021 -523,000.00
Mar 31, 2021 -1.21 Mn
Dec 31, 2020 -753,000.00
Sep 30, 2020 71,000.00